J9354 Ado-Trastuzumab Emtansine - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Ado-Trastuzumab Emtansine

Brand Name:

Kadcyla

Strength:

1mg

HCPCS:

J9354

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Drug Antibody Conjugate

Minor Drug Class:

HER2

Oral (Y/N):

No

FDA Approval Year:

2013

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2014

CMS Discontinuation Date:

Status:

In Use